Dr. Christopher Scott Bryant, MD

Dr. Bryant practices at Osceola Surgical Associates in Orlando, Florida.

Dr. Bryant's NPI, 1801836366, was assigned on June 6, 2006. Dr. Bryant graduated from University of Arkansas College of Medicine in 1999. Dr. Bryant holds Florida license ME 122592.

Dr. Bryant's primary practice is Osceola Surgical Associates, at 3438 Lawton Rd, Orlando, FL 32803 in Orange County. The practice phone is (407) 870-0808.

Dr. Bryant's primary practice is Osceola Surgical Associates in Orlando, Florida. Dr. Bryant is also affiliated with AdventHealth Orlando. The medical group on file is Women's Care. Dmand AI also links Dr. Bryant to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bryant practices, 5 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Bryant's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Bryant is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Bryant's licenses on file in 5 states: Florida, Arkansas, Mississippi, Tennessee and Michigan.

Dmand AI lists hysterectomy among the conditions Dr. Bryant treats.

CMS data shows 202 Medicare services from Dr. Bryant across 7 procedure codes in 2024, for 127 Medicare patients. Medicare paid $21,482 for them.

CMS counts 127 Medicare patients who saw Dr. Bryant in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bryant's median patient age at 51, with 99% women.

In 2024, Dr. Bryant wrote 406 Medicare Part D claims for 113 patients. 95% of them were for generic drugs. CMS names the drug for 313 of them, across 7 drugs with 11 or more claims each, at $3,449 in total drug cost. In 2023, CMS named 216 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bryant for performance year 2024, reported individually. Dr. Bryant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bryant as offering telehealth. CMS counts 16 procedures of removal of the uterus by Dr. Bryant, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 55 papers to Dr. Bryant, published from 2008 to 2014. 2008 was the busiest year, with 7. The most frequent topics are Ovarian Neoplasms, SEER Program and Endometrial Neoplasms. Dr. Bryant has published most often in Gynecol Oncol. Dr. Bryant's most frequent co-authors are Jay Pravin Shah, MD, Anthony Nosa Imudia, MD and Shelly Marie Seward, MD.

CMS Open Payments shows 112 general payments to Dr. Bryant from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Aspira Women's Health Inc paid the most, $20,891.

Dmand AI lists 11 awards for Dr. Bryant, most recently CMS Stage 1 EHR in 2013.

Dr. Bryant graduated from University of Arkansas College of Medicine in 1999. Dr. Bryant is a member of American College of Obstetricians and Gynecologists.

Dr. Bryant is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.